Characteristics and clinical outcomes of patients with systemic lupus erythematosus initiating anifrolumab in a real-world setting in Spain (AZAHAR study): an observational study protocol.

Saved in:
Bibliographic Details
Title: Characteristics and clinical outcomes of patients with systemic lupus erythematosus initiating anifrolumab in a real-world setting in Spain (AZAHAR study): an observational study protocol.
Authors: Galindo-Izquierdo M; Rheumatology Department, Instituto de Investigación Hospital 12 de Octubre, Madrid, Spain., Bahamontes-Rosa N; Biopharmaceuticals Medical, AstraZeneca, Madrid, Spain., Sarto-Ferres B; Biopharmaceuticals Medical, AstraZeneca, Madrid, Spain., Galvez-Fernandez M; Biopharmaceuticals Medical, AstraZeneca, Madrid, Spain marta.galvez@astrazeneca.com., Cortés-Hernández J; Rheumatology Department, Hospital Vall d'Hebron, Barcelona, Spain.
Source: Lupus science & medicine [Lupus Sci Med] 2025 Feb 12; Vol. 12 (1). Date of Electronic Publication: 2025 Feb 12.
Publication Type: Clinical Trial Protocol; Journal Article
Journal Info: Publisher: BMJ Country of Publication: England NLM ID: 101633705 Publication Model: Electronic Cited Medium: Print ISSN: 2053-8790 (Print) Linking ISSN: 20538790 NLM ISO Abbreviation: Lupus Sci Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2053-8790
DOI:10.1136/lupus-2024-001486